Galera Therapeutics schedules 2024 annual meeting for Feb 24, 2025; sets proposal deadline Dec 30

Galera Therapeutics, Inc.

Annual meeting set for February 24, 2025; deadline for stockholder proposals and director nominations is December 30, 2024.
Stockholders must comply with bylaw informational requirements; notice to secretary Joel Sussman at Malvern, PA address.
Universal proxy rule compliance requires additional notice for solicitations in support of non-company nominees by same deadline (Dec 30).
Proposals for inclusion in proxy materials under Rule 14a-8 must be received by Dec 30 to be considered timely.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.